For instance, the present program has reached a fairly comparable coverage for colorectal, breast, and cervical cancers with screening programs in the United States (29), but only limited screening services were provided for liver cancer and lung cancer due to the relatively high cost but low sensitivity of the initial screening tests like AFP test, ultrasonic, and chest X-ray examinations. The gene discussed is AFP; the disease is lung cancer.